Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide-formoterol treatment.

about

H-NMR-based metabolic profiling of healthy individuals and high-resolution CT-classified phenotypes of COPD with treatment of tiotropium bromide

P2860

Q57491079-D38CC378-928A-4FED-8A62-A0CCF76A855D

P2860

Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide-formoterol treatment.

Item

http://www.wikidata.org/entity/Q47103106

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Metabolic changes of different ...... desonide-formoterol treatment.

@en

Metabolic changes of different ...... desonide-formoterol treatment.

@nl

type

Item

label

Metabolic changes of different ...... desonide-formoterol treatment.

@en

Metabolic changes of different ...... desonide-formoterol treatment.

@nl

prefLabel

Metabolic changes of different ...... desonide-formoterol treatment.

@en

Metabolic changes of different ...... desonide-formoterol treatment.

@nl

P1476

Metabolic changes of different ...... desonide-formoterol treatment.

@en

P2093

Cheng Wang

http://www.w3.org/2001/XMLSchema#string

Dang Tang

http://www.w3.org/2001/XMLSchema#string

Jian-Qing Zhang

http://www.w3.org/2001/XMLSchema#string

Jun-Xiong Li

http://www.w3.org/2001/XMLSchema#string

Li-Zhou Fang

http://www.w3.org/2001/XMLSchema#string

Ling Liu

http://www.w3.org/2001/XMLSchema#string

Lu-Ming Dai

http://www.w3.org/2001/XMLSchema#string

Wei-Ping Fu

http://www.w3.org/2001/XMLSchema#string

P2860

Succinate: a metabolic signal in inflammation.

Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals.

Human metabolic phenotype diversity and its association with diet and blood pressure.

Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease.

Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease.

Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.

Potential importance of leucine in treatment of obesity and the metabolic syndrome.

Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.

Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule.

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation

P304

3511-3521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S152134

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29255358

http://www.w3.org/2001/XMLSchema#string

P932

5723127

http://www.w3.org/2001/XMLSchema#string

Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide-formoterol treatment.

about

P2860

P2860

Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide-formoterol treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932